| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07088068 A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in… |
Trial sites expanded: 153 -> 159 locations |
| 2026-05-28 | NCT07457580 Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of… |
Trial sites expanded: 4 -> 11 locations |
| 2026-05-28 | NCT07360080 Long-Term Outcomes of Teplizumab in Routine Clinical Care |
Trial sites expanded: 2 -> 8 locations |
| 2026-05-23 | NCT07088068 A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in… |
Trial sites expanded: 141 -> 153 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-27 | NCT07610213 Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05757713 | Teplizumab in Pediatric Stage 2 Type 1 Diabetes | Diabetes Mellitus, Type 1 | Active, Not Recruiting |
| Phase 3 | |||
| NCT07088068 | A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in… | Type 1 Diabetes Mellitus | Recruiting |
| Phase 2 | |||
| NCT06791291 | Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes | Type 1 Diabetes Mellitus | Recruiting |
| NCT07216391 | Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG | Type 1 Diabetes Mellitus | Not Yet Recruiting |
| Phase 1 | |||
| NCT07610213 | Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease… | Type 1 Diabetes Mellitus (T1DM) | Not Yet Recruiting |
| Not specified | |||
| NCT06481904 | Registry for Stage 2 Type 1 Diabetes | Type 1 Diabetes | Recruiting |
| NCT07360080 | Long-Term Outcomes of Teplizumab in Routine Clinical Care | Type 1 Diabetes | Recruiting |
| NCT07457580 | Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of… | Type 1 Diabetes | Recruiting |